Is Fredun Pharmaceuticals a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Fredun Pharmaceuticals Ltd is a average quality company .

Is Fredun Pharmaceuticals undervalued or overvalued?

The key valuation ratios of Fredun Pharmaceuticals Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone .

What is Fredun Pharmaceuticals share price return in the past 10 years?

Data is not available for this company

Is Fredun Pharmaceuticals a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Fredun Pharmaceuticals Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

What is the P/E ratio of Fredun Pharmaceuticals?

The latest standalone P/E ratio of Fredun Pharmaceuticals as of 20-Dec-2024 is 20.01.

What is the P/B ratio of Fredun Pharmaceuticals?

The latest standalone P/B ratio of Fredun Pharmaceuticals as of 20-Dec-2024 is 2.70.

What is the 52-week high and low of Fredun Pharmaceuticals?

The 52-week high of Fredun Pharmaceuticals is Rs. 1054.00 and the 52-week low is Rs. 650.00.

Fredun Pharmaceuticals Ltd - Stock Valuation and Financial Performance

Name: Fredun Pharmaceuticals
Brand: Fredun Pharmaceuticals

BSE: 539730 | NSE: | Pharmaceuticals & Drugs | Small Cap

Place order

Fredun Pharma Share Price

₹749.60 -3.70 -0.49%
as on 20-Dec'24 16:59

10 Year X-Ray of Fredun Pharma:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
ROCE % ⓘ	14.2%	24.7%	18.2%	15.9%	20.6%	10.4%	9.5%	13.2%	17.6%	17.1%	-
Value Creation Index ⓘ	0.0	0.8	0.3	0.1	0.5	-0.3	-0.3	-0.1	0.3	0.2	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	25.3	42.3	56.7	59.6	97	113	134	224	275	348	388
Sales YoY Gr.	-	67.1%	34%	5%	62.9%	16.2%	18.7%	67.7%	22.4%	26.8%	-
Adj EPS ⓘ	1.3	4.4	3.5	4.9	11.5	4.4	4.9	12.4	21.6	32.2	37.5
YoY Gr.	-	238.9%	-20.7%	38.4%	136.6%	-62.2%	13.3%	151.6%	73.5%	49.3%	-
BVPS (₹) ⓘ	11.5	15.7	20.1	64.7	97.7	103.6	108	153.1	194.3	255.2	277.2
Adj Net Profit ⓘ	0.3	1.1	0.8	1.7	4.6	1.7	2	5.5	9.8	15.1	18
Cash Flow from Ops. ⓘ	1.8	3.3	4	17.3	0.8	-10.6	0.2	-2.4	-14.4	-0.4	-
Debt/CF from Ops. ⓘ	5.1	4.7	4.6	0.6	23.1	-3.3	233.3	-22.2	-6	-240.5	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	33.8%	29.1%	37.5%	26.8%
Adj EPS ⓘ	42.7%	22.8%	86.8%	49.3%
BVPSⓘ	41.1%	21.2%	33.2%	31.3%
Share Price	-	28.6%	0.7%	-15.1%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
Return on Equity % ⓘ	10.4	29.7	14.8	11.3	15	4.3	4.7	9.9	11.9	13.9	14.1
Op. Profit Mgn % ⓘ	6.7	9.8	6	9.6	10.5	7.4	7	6.2	10.1	10.9	11.9
Net Profit Mgn % ⓘ	1.2	2.5	1.5	2.8	4.7	1.5	1.5	2.5	3.6	4.3	4.6
Debt to Equity ⓘ	3.1	3.9	2.5	0.5	0.5	0.8	0.9	0.8	1	0.9	0.1
Working Cap Days ⓘ	167	174	200	261	230	290	324	230	244	248	113
Cash Conv. Cycle ⓘ	18	28	12	-31	15	98	111	100	135	149	36

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 14.10%

Sales growth is growing at healthy rate in last 3 years 37.51%

Net Profit is growing at healthy rate in last 3 years 86.76%

Debt to equity has declined versus last 3 years average to 0.88

Sales growth is good in last 4 quarters at 29.11%

No data to display

Latest Financials - Fredun Pharmaceuticals Ltd.

	Standalone	Consolidated
TTM EPS (₹)	37.5	-
TTM Sales (₹ Cr.)	388	-
BVPS (₹.) ⓘ	277.2	-
Reserves (₹ Cr.) ⓘ	126	-
P/BV ⓘ	2.70	-
PE ⓘ	20.01	-

From the Market
52 Week Low / High (₹)	650.00 / 1054.00
All Time Low / High (₹)	12.50 / 1428.00
Market Cap (₹ Cr.)	354
Equity (₹ Cr.)	4.7
Face Value (₹)	10
Industry PE ⓘ	44.3

Management X-Ray of Fredun Pharma:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Fredun Pharma

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Fredun Pharma

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Sales	25	42	57	60	97	113	134	224	275	348
Operating Expenses ⓘ	24	38	53	54	87	104	125	211	247	310
Manufacturing Costs	2	11	17	3	7	7	6	8	11	15
Material Costs	15	19	25	40	60	82	102	177	209	261
Employee Cost	3	4	5	5	8	9	9	11	12	12
Other Costs ⓘ	4	5	7	6	12	7	8	15	16	22
Operating Profit ⓘ	2	4	3	6	10	8	9	14	28	38
Operating Profit Margin (%)	6.5%	9.2%	5.9%	9.6%	10.3%	7.4%	7.0%	6.2%	10.1%	10.9%
Other Income ⓘ	0	1	2	0	1	1	1	2	2	1
Interest ⓘ	1	2	2	2	3	4	4	5	9	14
Depreciation ⓘ	1	1	1	1	1	2	2	2	3	4
Exceptional Items ⓘ	0	0	0	0	0	0	-1	0	0	0
Profit Before Tax ⓘ	1	2	2	3	6	2	3	9	18	21
Tax ⓘ	0	1	1	1	2	1	1	2	7	6
Profit After Tax	0	1	1	2	4	2	2	6	11	16
PAT Margin (%)	1.0%	2.5%	2.5%	2.9%	4.6%	1.7%	1.5%	2.8%	3.9%	4.5%
Adjusted EPS (₹)	1.1	4.5	5.4	4.2	11.2	4.8	5.1	14.3	23.8	33.3
Dividend Payout Ratio (%)	0%	13%	11%	14%	6%	14%	14%	5%	3%	2%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Equity and Liabilities
Shareholders Fund	3	4	7	22	39	41	43	68	88	120
Share Capital ⓘ	3	3	5	3	4	4	4	4	5	5
Reserves ⓘ	0	1	2	19	35	37	39	63	84	115
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	8	13	15	10	19	35	40	53	83	100
Long Term Debt	3	6	7	0	11	11	29	42	15	13
Short Term Debt	5	7	8	10	9	23	11	11	68	87
Trade Payables	7	16	23	39	34	46	60	49	59	63
Others Liabilities ⓘ	5	10	11	8	13	19	19	18	27	25
Total Liabilities ⓘ	23	43	56	79	105	141	162	187	257	308
Fixed Assets
Gross Block	13	21	28	25	35	37	38	42	52	63
Accumulated Depreciation	5	6	7	9	4	6	8	10	13	16
Net Fixed Assetsⓘ	8	15	21	16	31	31	30	32	39	47
CWIP ⓘ	1	0	0	11	0	0	0	0	0	0
Investmentsⓘ	0	0	0	0	0	0	0	0	0	1
Inventories	4	10	7	18	41	50	68	46	150	175
Trade Receivables	5	11	20	15	18	39	41	90	35	65
Cash Equivalents	1	1	1	1	1	3	1	2	3	1
Others Assetsⓘ	4	6	8	17	14	18	21	16	30	19
Total Assets ⓘ	23	43	56	79	105	141	162	187	257	308

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Cash Flow From Operating Activity ⓘ	2	3	4	17	1	-11	0	-2	-14	0
PBT ⓘ	1	2	2	2	6	2	2	9	17	21
Adjustment ⓘ	1	2	2	3	2	6	9	8	12	17
Changes in Working Capital ⓘ	0	-0	-0	13	-7	-19	-10	-19	-44	-39
Tax Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Cash Flow From Investing Activity ⓘ	-3	-6	-7	-8	-5	-1	-1	-4	-9	-8
Capex	-2	-7	-3	-1	-16	-1	-1	-4	-9	-8
Net Investments	0	0	0	0	0	0	0	0	0	0
Others ⓘ	-1	1	-4	-7	11	0	0	0	0	0
Cash Flow From Financing Activityⓘ	1	3	3	-8	4	14	-1	7	25	6
Net Proceeds from Shares ⓘ	0	5	2	-1	1	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	-4	7	1	18	13	7	-3
Interest Paid ⓘ	-1	-2	-2	-2	-3	-4	-4	-5	-9	-14
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	2	0	2	-1	0	17	-14	-1	28	22
Net Cash Flow ⓘ	0	1	-1	1	0	2	-2	1	1	-2

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Ratios
ROE (%)	9.68	33.46	33.88	13.02	14.59	4.74	4.77	11.42	13.86	15.03
ROCE (%)	14.23	24.67	18.16	15.9	20.56	10.36	9.53	13.15	17.64	17.13
Asset Turnover Ratio	1.25	1.28	1.14	0.88	1.05	0.92	0.88	1.29	1.24	1.23
PAT to CFO Conversion(x)	N/A	3	4	8.5	0.25	-5.5	0	-0.33	-1.27	0
Working Capital Days
Receivable Days	62	72	102	109	62	92	109	107	83	52
Inventory Days	57	63	55	78	111	148	161	93	131	170
Payable Days	144	223	290	285	221	178	190	112	94	85

Fredun Pharmaceuticals Ltd Stock News

Fredun Pharmaceuticals Ltd FAQs

What is the share price of Fredun Pharma?

Company share prices are keep on changing according to the market conditions. The closing price of Fredun Pharma on 20-Dec-2024 16:59 is ₹749.6.

What is the market cap of Fredun Pharma?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 20-Dec-2024 16:59 the market cap of Fredun Pharma stood at ₹353.9.